Tsutomu Ogata Selected Research

Leri-Weil syndrome

7/2016	Systematic molecular analyses of SHOX in Japanese patients with idiopathic short stature and Leri-Weill dyschondrosteosis.
10/2003	Longitudinal auxological study in a female with SHOX (short stature homeobox containing gene) haploinsufficiency and normal ovarian function.
12/2002	SHOX haploinsufficiency and its modifying factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tsutomu Ogata Research Topics

Disease

11	Hypospadias 02/2018 - 12/2006
10	Neoplasms (Cancer) 01/2021 - 01/2008
9	Antley-Bixler Syndrome Phenotype 01/2018 - 01/2005
8	Penis agenesis 01/2015 - 01/2002
7	Cryptorchidism (Undescended Testes) 02/2018 - 08/2005
6	Noonan Syndrome (Female Pseudo-Turner Syndrome) 08/2020 - 08/2002
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 02/2012
5	Gynecomastia 01/2021 - 06/2011
5	Azoospermia 01/2018 - 12/2002
5	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2017 - 06/2004
5	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 04/2016 - 02/2006
4	Pseudohypoparathyroidism 01/2018 - 01/2013
4	Combined Pituitary Hormone Deficiency 01/2013 - 02/2010
3	Inborn Genetic Diseases (Disease, Hereditary) 07/2022 - 01/2012
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2018 - 01/2016
3	Virilism (Virilization) 01/2018 - 05/2009
3	Hyperphosphatemia 01/2018 - 01/2013
3	Precocious Puberty 12/2017 - 01/2015
3	Leri-Weil syndrome 07/2016 - 12/2002
3	46,XY Disorder of Sex Development (Male Pseudohermaphroditism) 12/2012 - 05/2009
3	Kallmann Syndrome (Kallmann's Syndrome) 04/2006 - 03/2004
2	Imprinting Disorders 10/2022 - 01/2016
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2022 - 10/2021
2	Intellectual Disability (Idiocy) 05/2021 - 01/2015
2	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 09/2017
2	Diabetes Mellitus 01/2021 - 01/2010
2	Hypophosphatasia 01/2020 - 07/2017
2	Megalencephaly 01/2020 - 05/2014
2	XX Disorders of Sex Development 46 (Female Pseudohermaphroditism) 01/2019 - 05/2009
2	Hypercalcemia (Milk Alkali Syndrome) 01/2018 - 12/2013
2	Hypersensitivity (Allergy) 01/2018 - 01/2009
2	Prader-Willi Syndrome (Syndrome, Prader-Willi) 12/2017 - 06/2012
2	Silver-Russell Syndrome 12/2017 - 08/2012
2	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 10/2016 - 01/2014
2	Beckwith-Wiedemann Syndrome (Exomphalos Macroglossia Gigantism Syndrome) 12/2014 - 08/2012
2	Uniparental Disomy 04/2014 - 01/2014
2	Renal hypouricemia 03/2014 - 07/2004
2	Pituitary Dwarfism 02/2011 - 02/2010
2	LEOPARD Syndrome (Syndrome, LEOPARD) 10/2010 - 06/2005
2	Anophthalmos (Anophthalmia) 10/2008 - 02/2007
1	Focal Dermal Hypoplasia (Syndrome, Goltz) 01/2022

Drug/Important Bio-Agent (IBA)

11	SteroidsIBA 10/2018 - 12/2004
8	Estrogens (Estrogen)FDA Link 01/2022 - 03/2002
8	Testosterone (Sustanon)FDA Link 09/2016 - 12/2004
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
7	Hormones (Hormone)IBA 01/2018 - 06/2004
7	DNA (Deoxyribonucleic Acid)IBA 07/2016 - 01/2002
6	Insulin (Novolin)FDA Link 01/2021 - 03/2005
6	AndrogensIBA 10/2018 - 04/2016
6	Oxidoreductases (Dehydrogenase)IBA 04/2016 - 01/2005
5	due to increased aromatase activity familial gynecomastiaIBA 01/2021 - 06/2011
5	AutoantibodiesIBA 01/2018 - 01/2010
5	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2017 - 03/2004
5	EnzymesIBA 05/2014 - 07/2003
4	Phosphates (Orthophosphate)IBA 01/2020 - 01/2013
4	GonadotropinsIBA 12/2017 - 12/2004
4	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2014 - 01/2005
3	RNA Splice SitesIBA 01/2022 - 01/2012
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 08/2010
3	CalciumIBA 01/2020 - 12/2013
3	Androgen Receptors (Androgen Receptor)IBA 01/2018 - 07/2004
3	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2018 - 06/2004
3	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 10/2016 - 10/2013
3	GlucocorticoidsIBA 10/2016 - 10/2013
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2016 - 12/2004
3	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2016 - 12/2004
3	Growth Hormone (Somatotropin)IBA 01/2015 - 10/2008
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2015 - 01/2007
3	hydrogen sulfite (bisulfite)IBA 12/2014 - 08/2012
3	Aromatase (CYP19)IBA 07/2014 - 03/2014
3	Biological ProductsIBA 07/2013 - 01/2012
3	Nonsense Codon (Nonsense Mutation)IBA 01/2009 - 12/2006
3	Estrogen Receptor alphaIBA 05/2007 - 12/2002
3	Protein Tyrosine PhosphatasesIBA 06/2005 - 08/2002
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 02/2005 - 01/2002
2	SilverIBA 10/2022 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 03/2005
2	Human Growth Hormone (Saizen)FDA LinkGeneric 08/2020 - 02/2018
2	asfotase alfaIBA 01/2020 - 07/2017
2	Alkaline PhosphataseIBA 01/2020 - 07/2017
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 02/2018 - 07/2012
2	GTP-Binding Proteins (G-Protein)IBA 01/2018 - 01/2016
2	Dihydrotestosterone (Androstanolone)IBA 01/2018 - 07/2006
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 09/2016 - 01/2010
2	pregnanetrioloneIBA 04/2016 - 04/2012
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2015 - 12/2004
2	CreatinineIBA 12/2013 - 06/2004
2	Steroidogenic Factor 1IBA 10/2012 - 01/2009
2	bisphenol AIBA 01/2012 - 01/2012
2	Aromatase deficiencyIBA 05/2009 - 02/2006
2	Biotin (Vitamin H)FDA Link 01/2009 - 06/2008
2	Endocrine DisruptorsIBA 05/2007 - 08/2005
2	DioxinsIBA 02/2005 - 10/2004
2	testosterone enanthate (Delatestryl)FDA LinkGeneric 07/2004 - 07/2002
1	RNA (Ribonucleic Acid)IBA 07/2022
1	MannosyltransferasesIBA 10/2021
1	N,N-diacetylchitobioseIBA 10/2021
1	Mannose (D-Mannose)IBA 10/2021

Therapy/Procedure

8	Therapeutics 01/2021 - 07/2002
3	Ligation 01/2016 - 01/2013